BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 25, 1999
View Archived Issues
SuperGen to acquire Sparta stock and development portfolio
Read More
ZymeTx reports progress in development programs
Read More
Nippon Kayaku: Annual Report 1998
Read More
55 new chemical entities in the combined AstraZeneca pipeline
Read More
Phase II trial of G-3139 in NHL patients to commence at Royal Marsden Hospital
Read More
Monsanto: Q4 and year-end 1998 highlights
Read More
Searle's celecoxib: the first COX-2 inhibitor reaches the market
Read More
Pfizer's new macrolide antibiotics presented in patent literature
Read More
Beyond Viagra: FDA reviews new product approvals in 1998
Read More
Potent heterocyclic antithrombotic agents discovered by Lilly
Read More
Neurotransmitter reuptake-inhibitory piperidines designed at NeuroSearch
Read More
British Biotech continues search for MMP inhibitors
Read More
Preparation and use of neuronal NOS inhibitors disclosed by Astra
Read More
New 5-HT4 receptor ligands from Synthelabo, their synthesis and use
Read More
SWOG phase II study of safety and efficacy of rhIL-4 in malignant melanoma
Read More
Therapeutic advantages of paricalcitol further defined
Read More
Alpha-Beta Technology discontinues phase III trial of Betafectin
Read More
Oral L-arginine compared to placebo for efficacy in interstitial cystitis
Read More
Glaxo Wellcome and PowderJect expand DNA vaccine collaboration
Read More
Searle drops development of gpIIb/IIIa receptor antagonists
Read More
New insulin sensitizer is a coligand for PPARalpha and PPARgamma receptors
Read More
L-754030 will enter phase III testing for emesis
Read More
Another significant market introduction for basiliximab
Read More
